Cerevel Therapeutics Holdings Inc (CERE) Stock Price, Graph, News & Analysis
() | NASDAQ : CERE
$42.10 -$0.25 (-0.59%)
Market Status : Closed
Last Update :
5/17/2024 4:00:00 PM
cerevel therapeutics is a biopharmaceutical company focused on developing new therapies to treat disorders of the central nervous system (cns). the company has a portfolio of experimental neuroscience Read More
Historical Price Graph
Performance
| 1 Month | 3 Month | 6 Month | YTD | 1 Year | 3 Year | 5 Year |
|---|---|---|---|---|---|---|
| -0.09% | -1.1% | 70.86% | -0.71% | 31.73% | 78.24% | 247.93% |
Details
Exchange
NASDAQ
Industry
Website
cerevel.com
Sector
CEO
Anthony Coles Jr.
Total Employees
275
SIC Code
2834
Market Cap
$ 7.67 B
Key Statistics
Dividend Rate
$0.00
Last Dividend
Dividend Yield
P/E Ratio
Price Range (52 Week)
$19.59 - $43.59
Latest Volume
$ 1.19 M
Average Total Volume
$ 935.17 K
Outstanding Shares
182,194,722
Beta
75.02%
Similar Stocks
| Companyarrow_upward | Sectorarrow_upward | Latest Pricearrow_upward | Changearrow_upward |
|---|---|---|---|
| Oshkosh Corp (OSK) | Producer Manufacturing | $116.96 | $0.44 |
| Applied Industrial Technologies Inc. (AIT) | Distribution Services | $196.99 | $0.13 |
| Five Below Inc (FIVE) | Retail Trade | $137.54 | -$3.49 |
| Icahn Enterprises L P - Unit (IEP) | Producer Manufacturing | $16.83 | -$0.48 |
| Global X Funds - Global X U.S. Infrastructure Development ETF (PAVE) | Miscellaneous | $38.98 | $0.03 |
Cerevel Therapeutics Holdings Inc in News
Benzinga (CERE)
Cerevel Therapeutics Announces Positive Topline Results for Tavapadon in Phase 3 Adjunctive Trial for People Living with Parkinson''s Disease Tavapadon met the primary endpoint in the pivotal Phase 3 TEMPO-3 adjunctive trial, demonstrating a Apr 18, 2024 6:30 AM
Newswires (CERE,CICN)
Altech’s revolutionary battery technology has 50% less emissions than lithium-ion Studies indicate Altech’s Sodium-Chloride Solid State CERENERGY® batteries benefit from a far lower Jul 10, 2023 9:09 PM
The AM Reporter (CERE,CERE)
Cerevel Therapeutics (NASDAQ:CERE) Stock Price Down 2.6% Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Free Report)’s share price traded down 2.6% durin Jul 9, 2023 3:16 AM
Seeking Alpha (CERE)
Cerevel: High Priced Stock Doing Interesting Science Cerevel has some interesting data in various CNS indications. However, the company has a very high v Jun 4, 2023 6:38 AM
US Post News (CERE)
Can you still get a good price for Cerevel Therapeutics Holdings Inc. (CERE) Shares at this point? In Tuesday’s session, Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) marked $26.93 per share, down Mar 8, 2023 10:08 AM
US Post News (CERE)
Was anything positive for Cerevel Therapeutics Holdings Inc. (CERE) stock last session? Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) marked $25.68 per share on Monday, up from a previo Feb 28, 2023 10:40 AM
US Post News (CERE)
You Should Read This Analysis Before Investing in Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) In the current trading session, Cerevel Therapeutics Holdings Inc.’s (CERE) stock is trading at the Feb 23, 2023 12:16 PM
Seeking Alpha (CERE)
CERE stock drops amid delay for lead clinical programs (NASDAQ:CERE) Cerevel Therapeutics (CERE) lost ~14% on Wednesday, marking the steepest selloff since August after Feb 22, 2023 3:30 PM
Stocks Register (CERE)
Thinking About Buying Cerevel Therapeutics Holdings Inc. Stock? Here’s What You Need To Know. Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) shares, rose in value on Friday, 01/20/23, with the Jan 21, 2023 2:00 PM
US Post News (CERE)
Can you now get a good deal on Cerevel Therapeutics Holdings Inc.’s shares? The share price of Cerevel Therapeutics Holdings Inc. (NASDAQ:CERE) rose to $31.08 per share on Tues Jan 11, 2023 8:32 AM
Common Questions Related to Cerevel Therapeutics Holdings Inc
When is Cerevel Therapeutics Holdings Inc next earning date?
Cerevel Therapeutics Holdings Inc next earning date is 2024-08-07
What is dividend yield of Cerevel Therapeutics Holdings Inc stock?
Cerevel Therapeutics Holdings Inc dividend yield is 0 and Cerevel Therapeutics Holdings Inc announced last dividend in of amount $0.00/stock.
What is Cerevel Therapeutics Holdings Inc stock symbol?
Cerevel Therapeutics Holdings Inc traded in NASDAQ stock exchange and the stock symbol/ticker is CERE
What is the latest share price of Cerevel Therapeutics Holdings Inc (CERE)? or What is Cerevel Therapeutics Holdings Inc stock price today?
Cerevel Therapeutics Holdings Inc latest stock price is $42.10
Where is Cerevel Therapeutics Holdings Inc headquarter?
Cerevel Therapeutics Holdings Inc headquarter is at – 222 Jacobs Street, Cambridge, MA, US
What is the total market cap of Cerevel Therapeutics Holdings Inc company?
The total market value of Cerevel Therapeutics Holdings Inc stock is $ 7.67 B
What is the Beta of Cerevel Therapeutics Holdings Inc stock?
Cerevel Therapeutics Holdings Inc Beta is 0.7501672930875082
Related Tags
Cerevel Therapeutics Holdings Inc stock price history, Cerevel Therapeutics Holdings Inc stock quote, CERE current stock price, Cerevel Therapeutics Holdings Inc dividend yield, Cerevel Therapeutics Holdings Inc Dividend, How much is Cerevel Therapeutics Holdings Inc worth